Search for: "SANOFI-AVENTIS U.S. INC." Results 41 - 60 of 120
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
15 Jun 2014, 8:46 pm by Patent Docs
Declaratory judgment of unenforceability of U.S. [read post]
22 Apr 2014, 7:41 am
United Parcel Serv., Inc., 665 F.3d 68, 73 (3d Cir. 2012).Sanofi-Aventis Deutschland GMBH at *12.Jury InstructionsYou may make an adverse inference in this case against Glenmark. [read post]
19 Apr 2014, 8:50 am by Lawrence B. Ebert
Rev. 629 (2009) :Teva recruited a predecessor of Sanofi-Aventis to help sell its multiple sclerosis drug Copaxone. [read post]
25 Jul 2013, 11:43 am by Dennis Crouch
Lucier was a thalidomide case against GSK, SmithKline Beecham, Sanofi-Aventis, Grunethal, and others and was originally filed in Pennsylvania state court. [read post]
7 Sep 2012, 3:23 pm by Bexis
Allergan USA, Inc., 2012 WL 3692396 (E.D. [read post]
9 Jun 2012, 5:13 am by Russell Beck
” The former Sanofi-Aventis chemist, Yuan Li, who pled guilty in January to passing trade secrets to a Chinese company was sentenced on May 8, 2012 to 18 months in prison and ordered to pay $131,000 in restitution. [read post]
10 May 2012, 7:45 am
  A Sanofi Aventis scientist has been sentenced to 18 months in prison for stealing the pharmaceutical company's trade secrets and putting them up for sale through the U.S. branch of a Chinese chemicals company. [read post]
19 Apr 2012, 10:00 pm by Stephanie Figueroa
If there are any patent blogs you think should be highlighted by our Top 5, please comment on this post and we'll check them out. 1) CAFC Blog: Revisiting Therasense, CAFC Finds That An Inventor's Subjective Belief That Submission of Documents Was Unnecessary May Not be Sufficient to Avoid a Showing Of Intent to Deceive - This post discusses Aventis Pharma S.A. and Sanofi-Aventis U.S. [read post]
19 Apr 2012, 10:00 pm by Stephanie Figueroa
If there are any patent blogs you think should be highlighted by our Top 5, please comment on this post and we'll check them out. 1) CAFC Blog: Revisiting Therasense, CAFC Finds That An Inventor's Subjective Belief That Submission of Documents Was Unnecessary May Not be Sufficient to Avoid a Showing Of Intent to Deceive - This post discusses Aventis Pharma S.A. and Sanofi-Aventis U.S. [read post]
7 Feb 2012, 2:25 pm by FDABlog HPM
’s (“Sandoz’s”) ANDA No. 077857 for a generic version of Sanofi-aventis U.S. [read post]
23 Nov 2011, 1:13 pm by Tom Lamb
Sanofi-aventis Canada Inc., in collaboration with Health Canada, would like to inform patients of important safety information related to the use of the heart drug Multaq (dronedarone).... (12/13/11) ______________________________________________________________________________ In mid-June 2011 drug regulators first turned their attention to cardiovascular side effects associated with the use of Multaq (dronedarone), soon after Sanofi announced that it… [read post]